Antengene To Present One Oral and Four Abstracts at ASCO 2024 ...Middle East

Oral Presentation：a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer Three Poster presentations: Phase I/II studies of ATG-031 (anti-CD24 monoclonal antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), and selinexor (XPO1...

Hence then, the article about antengene to present one oral and four abstracts at asco 2024 was published today ( Friday 24/05/2024 - 03:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene To Present One Oral and Four Abstracts at ASCO 2024 )

Also on site :

• Peter Alexander is leaving NBC after years of being passed over for top anchor jobs: source
• London anti far-right march – latest: Police brace for unrest as thousands of protesters descend on capital
• The Japanese Concept a Psychologist Swears by To Find Purpose in Life